C1q肿瘤坏死因子相关蛋白9(C1QTNF9)重组蛋白
Recombinant C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9)
CTRP9; C1QTNF9A; AQL1; Complement C1q and tumor necrosis factor-related protein 9A
- 编号RPR877Hu01
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌
- 预测分子量36.2kDa
- 实际分子量38kDa(差异分析请参阅说明书)
- 片段与标签Gln20~Pro333 with N-terminal His Tag
- 缓冲液成份100mM NaHCO3, 500mM NaCl缓冲液（pH8.3,含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性状冻干粉
- 纯度> 95%
- 等电点8.7
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1080 ¥ 2700 ¥ 5400 ¥ 16200 ¥ 40500
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
SDS-PAGE图
-
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPR877Hu01 | C1q肿瘤坏死因子相关蛋白9(C1QTNF9)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAR877Hu01 | C1q肿瘤坏死因子相关蛋白9(C1QTNF9)多克隆抗体 | WB; IHC; ICC; IP. |
| MAR877Hu21 | C1q肿瘤坏死因子相关蛋白9(C1QTNF9)单克隆抗体 | WB; IHC; ICC; IP. |
| SER877Hu | C1q肿瘤坏死因子相关蛋白9(C1QTNF9)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMR877Hu | C1q肿瘤坏死因子相关蛋白9(C1QTNF9)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Int J Obes (Lond). | Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. [Pubmed: 24357853] |
| J Clin Endocrinol Metab.? | Association of Serum C1q/TNF-Related Protein-9 Concentration With Arterial Stiffness in Subjects With Type 2 Diabetes [Pubmed:25105737] |
| J Clin Endocrinol Metab. | C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery [Pubmed:26982010] |
| PLoS One. | Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose. [pubmed:28207876] |
| Journal of Diabetes Research | Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients withType 2 Diabetes without Renal Dysfunction. [pubmed:28070523] |
| diabetes research and clinical practice | Circulating CTRP9 levels are increased in patients with newly diagnosed type 2 diabetes and correlated with insulin resistance [pubmed:28743061] |
| PLoS One | Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery … [Pubmed:29381773] |
| archives of insect biochemistry and physiology | Effect of a single bout of resistance exercise on zinc-α2-glycoprotein [Pubmed: 31686532] |
| J Diabetes Investig | Association of serum CTRP9 levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus [33417302] |
| Neurol Ther | Association Between Serum C1q Tumor Necrosis Factor-Related Protein 9 and the Clinical Characteristics and Prognosis of Ischemic Stroke [34727346] |
留言咨询
